DIG
EBACU

DeepCurrents Investment Group’s European Biotech Acquisition Corp. Units EBACU Stock Holding History

DeepCurrents Investment Group’s Portfolio EBACU Stock Details EBACU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-17,730
Closed -$176K – 250
2021
Q3 		$176K Hold
17,730
– – 0.01% 149
2021
Q2 		$177K Sell
17,730
-7,270
-29% -$72.8K 0.01% 170
2021
Q1 		$251K Buy
+25,000
New +$250K 0.01% 125

Other funds holding EBACU

Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
PMAM
Picton Mahoney Asset Management Toronto, Ontario, Canada $13.5B AUM 50.48% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
SMA
Sage Mountain Advisors Atlanta, Georgia $1.43B AUM 16.47% 1-Year Est. Return
MTCM
Mint Tower Capital Management Amsterdam, Netherlands $1.12B AUM 19.06% 1-Year Est. Return
Calamos Advisors
Calamos Advisors Naperville, Illinois $28.2B AUM 21.78% 1-Year Est. Return
WC
Wealthspring Capital West Harrison, New York $448M AUM 8.38% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return

DeepCurrents Investment Group's EBACU Position: Q4 2021 in Review

DeepCurrents Investment Group sold out of European Biotech Acquisition Corp. Units (EBACU) in Q4 2021, closing a stake of 17,730 shares — an estimated $176K sold.

DeepCurrents Investment Group first reported a position in EBACU in Q1 2021 and held it in 3 quarters. The position peaked at $251K in Q1 2021. 26 funds tracked by Wall St. Rank hold EBACU as of Q4 2021.

  • DeepCurrents Investment Group reported no remaining European Biotech Acquisition Corp. Units position as of Q4 2021 after selling out during the quarter.
  • DeepCurrents Investment Group sold 17,730 European Biotech Acquisition Corp. Units shares in Q4 2021, an estimated $176K.
  • DeepCurrents Investment Group first reported a position in European Biotech Acquisition Corp. Units in Q1 2021 and held it in 3 quarters.
  • DeepCurrents Investment Group's European Biotech Acquisition Corp. Units position peaked at $251K in Q1 2021.
  • 26 funds tracked by Wall St. Rank held European Biotech Acquisition Corp. Units as of Q4 2021.

Based on DeepCurrents Investment Group's 13F filing for Q4 2021, filed 14 Feb 2022.